# A Study on the Live-Attenuated Herpes Zoster Vaccine for Sequential Booster Immunization Following Recombinant Herpes Zoster Vaccine

> **NCT07753265** · EARLY_PHASE1 · NOT_YET_RECRUITING · sponsor: **Changchun BCHT Biotechnology Co.** · enrollment: 100 (estimated)

## Conditions studied

- Herpse Zoster

## Interventions

- **BIOLOGICAL:** live-attenuated zoster vaccine

## Key facts

- **NCT ID:** NCT07753265
- **Lead sponsor:** Changchun BCHT Biotechnology Co.
- **Sponsor class:** INDUSTRY
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-08-13
- **Primary completion:** 2026-09-20
- **Final completion:** 2026-09-20
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2026-08-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07753265

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07753265, "A Study on the Live-Attenuated Herpes Zoster Vaccine for Sequential Booster Immunization Following Recombinant Herpes Zoster Vaccine". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07753265. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*